Sign up
Quantellect · Congress · Trade Detail
IHEiShares US Pharmaceuticals (NYSEArca)
RepublicanSenate

Bill Cassidy bought iShares US Pharmaceuticals (NYSEArca) (IHE)

Bill Cassidy (R-LA), a U.S. Senator, has disclosed 2 trades in iShares US Pharmaceuticals (NYSEArca) (IHE) since 2015, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Bill Cassidy bought $1,001 - $15,000 of iShares US Pharmaceuticals (NYSEArca) (IHE) on August 27, 2015. Since that trade, IHE is up +117.74% against the S&P 500 up +337.95%, an outperformance of -220.21%.

Across these filings, Bill Cassidy has been a balanced trader of IHE (a buy-to-sell ratio of 1.00). The most recent disclosed IHE transaction shown was dated January 31, 2018. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

IHE trades
2
Disclosed Vol
$16K
Buys
1
50%
Sells
1
50%
Buy / Sell
1.00
ratio
First → Last
2015–2018

Bill Cassidy's IHE trades vs the price

IHE is up +117.74% since Bill Cassidy bought on August 27, 2015, versus +337.95% for the S&P 500.

Performance since this trade

Price change since trade
+117.74%
S&P 500 change since trade
+337.95%
Outperformance vs S&P 500
-220.21%

All Bill Cassidy IHE trades

TradedTypeSizeReturnEst. profit
January 31, 2018SELL$46.00+125.00%
August 27, 2015BUY$47.53+117.74%-$3K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Bill Cassidy & IHE trading FAQ

Is it legal for Bill Cassidy to trade iShares US Pharmaceuticals (NYSEArca) (IHE) stock?

Yes. Members of Congress are allowed to trade individual stocks, including iShares US Pharmaceuticals (NYSEArca) (IHE), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Bill Cassidy buy IHE?

Bill Cassidy disclosed a purchase of $1,001 - $15,000 of iShares US Pharmaceuticals (NYSEArca) (IHE) on August 27, 2015, according to public STOCK Act filings.

How has IHE performed since Bill Cassidy's trade?

Since Bill Cassidy bought IHE on August 27, 2015, the stock is up +117.74%, versus +337.95% for the S&P 500 over the same period, an outperformance of -220.21%.

How many times has Bill Cassidy traded IHE?

Bill Cassidy has disclosed 2 IHE trades since 2015 (1 purchase and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional IHE trades?

Quantellect tracks every disclosed congressional trade in iShares US Pharmaceuticals (NYSEArca) (IHE) on the iShares US Pharmaceuticals (NYSEArca) congressional trading page, which aggregates filings across all members of Congress.

Bill Cassidy's IHE tradesAll congressional filings for iShares US Pharmaceuticals (NYSEArca)Bill Cassidy's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.